Consonance Capital Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-2,882,773
| Closed | -$32.1M | – | 31 |
|
|
2019
Q2 | $32.1M | Sell |
2,882,773
-864,680
| -23% | -$9.64M | 2.27% | 17 |
|
|
2019
Q1 | $44M | Sell |
3,747,453
-2,464,511
| -40% | -$28.9M | 2.78% | 13 |
|
|
2018
Q4 | $83M | Buy |
6,211,964
+1,173,090
| +23% | +$15.7M | 6.1% | 7 |
|
|
2018
Q3 | $70.6M | Buy |
5,038,874
+410,457
| +9% | +$5.75M | 3.8% | 15 |
|
|
2018
Q2 | $72.8M | Sell |
4,628,417
-560,000
| -11% | -$8.8M | 4.69% | 9 |
|
|
2018
Q1 | $85.3M | Sell |
5,188,417
-591,089
| -10% | -$9.72M | 7.8% | 3 |
|
|
2017
Q4 | $104M | Buy |
5,779,506
+1,897,283
| +49% | +$34.3M | 9.43% | 2 |
|
|
2017
Q3 | $74.9M | Sell |
3,882,223
-1,922,117
| -33% | -$37.1M | 8.29% | 5 |
|
|
2017
Q2 | $68.5M | Buy |
5,804,340
+634,700
| +12% | +$7.49M | 8.07% | 7 |
|
|
2017
Q1 | $56.7M | Buy |
+5,169,640
| New | +$56.7M | 5.94% | 8 |
|